A
Azaibi Tamin
Researcher at Centers for Disease Control and Prevention
Publications - 78
Citations - 19247
Azaibi Tamin is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Coronavirus & Antibody. The author has an hindex of 32, co-authored 70 publications receiving 15271 citations. Previous affiliations of Azaibi Tamin include National Center for Immunization and Respiratory Diseases & University of Pittsburgh.
Papers
More filters
Journal ArticleDOI
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.
Neeltje van Doremalen,Trenton Bushmaker,Dylan H. Morris,Myndi G. Holbrook,Amandine Gamble,Brandi N. Williamson,Azaibi Tamin,Jennifer L Harcourt,Natalie J. Thornburg,Susan I. Gerber,James O. Lloyd-Smith,Emmie de Wit,Vincent J. Munster +12 more
TL;DR: Aerosol and Surface Stability of SARS-CoV-2 In this research letter, investigators report on the stability of Sars-CoVs and the viability of the two virus under experimental conditions.
Journal ArticleDOI
Characterization of a novel coronavirus associated with severe acute respiratory syndrome.
Paul A. Rota,M. Steven Oberste,Stephan S. Monroe,W. Allan Nix,Ray Campagnoli,Joseph P. Icenogle,Silvia Peñaranda,Bettina Bankamp,Kaija Maher,Min hsin Chen,Suxiong Tong,Azaibi Tamin,Luis Lowe,Michael Frace,Joseph L. DeRisi,Qi Chen,David Wang,Dean D. Erdman,Teresa C. T. Peret,Cara C. Burns,Thomas G. Ksiazek,Pierre E. Rollin,Anthony Sanchez,Stephanie L. Liffick,Brian P. Holloway,Josef Limor,Karen A. McCaustland,Mellissa Olsen-Rasmussen,Ron A. M. Fouchier,Stephan Günther,Albert Osterhaus,Christian Drosten,Mark A. Pallansch,Larry J. Anderson,William J. Bellini +34 more
TL;DR: Phylogenetic analyses and sequence comparisons showed that SARS-CoV is not closelyrelated to any of the previouslycharacterized coronaviruses.
Journal ArticleDOI
Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.
Melissa M. Arons,Kelly M Hatfield,Sujan C Reddy,Anne Kimball,Allison E James,Jesica R. Jacobs,Joanne Taylor,Kevin B. Spicer,Ana C Bardossy,Lisa P. Oakley,Sukarma Tanwar,Jonathan W Dyal,Josh Harney,Zeshan Chisty,Jeneita M. Bell,Mark Methner,Prabasaj Paul,Christina M. Carlson,Heather P. McLaughlin,Natalie J. Thornburg,Suxiang Tong,Azaibi Tamin,Ying Tao,Anna Uehara,Jennifer L Harcourt,Shauna Clark,Claire Brostrom-Smith,Libby C. Page,Meagan Kay,James S. Lewis,Patty Montgomery,Nimalie D. Stone,Thomas A. Clark,Margaret A. Honein,Jeffrey S. Duchin,John A. Jernigan +35 more
TL;DR: Rapid and widespread transmission of SARS-CoV-2 was demonstrated in this skilled nursing facility and infection-control strategies focused solely on symptomatic residents were not sufficient to prevent transmission.
Journal ArticleDOI
Nipah Virus: A Recently Emergent Deadly Paramyxovirus
Kaw Bing Chua,William J. Bellini,Paul A. Rota,Brian H. Harcourt,Azaibi Tamin,Sai Kit Lam,Thomas G. Ksiazek,Pierre E. Rollin,Sherif R. Zaki,Wun-Ju Shieh,Cynthia S. Goldsmith,Duane J. Gubler,John T. Roehrig,Bryan T. Eaton,A. R. Gould,James G. Olson,P. Daniels,Ai Ee Ling,Clarence J. Peters,Larry J. Anderson,Brian W. J. Mahy +20 more
TL;DR: Electron microscopic, serologic, and genetic studies indicate that the Nipah virus belongs to the family Paramyxoviridae and is most closely related to the recently discovered Hendra virus, and it is suggested that these two viruses are representative of a new genus within the familyparamyxviridae.
Journal ArticleDOI
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.
Timothy P. Sheahan,Amy C. Sims,Shuntai Zhou,Rachel L. Graham,Andrea J. Pruijssers,Maria L. Agostini,Sarah R. Leist,Alexandra Schäfer,Kenneth H. Dinnon,Laura J. Stevens,James D. Chappell,Xiaotao Lu,Tia M. Hughes,Amelia S. George,Collin S. Hill,Stephanie A. Montgomery,Ariane J. Brown,Gregory R. Bluemling,Michael G. Natchus,Manohar Saindane,Alexander A. Kolykhalov,George R. Painter,Jennifer L Harcourt,Azaibi Tamin,Natalie J. Thornburg,Ronald Swanstrom,Mark R. Denison,Ralph S. Baric +27 more
TL;DR: It is shown that the ribonucleoside analog β-d-N4-hydroxycytidine (NHC; EIDD-1931) has broad-spectrum antiviral activity against SARS- coV-2, MERS-CoV, SARS, and related zoonotic group 2b or 2c bat-CoVs, as well as increased potency against a CoV bearing resistance mutations to the nucleosid analog inhibitor remdesivir